C-Peptide Test: Normal Range and How It Separates Type 1 from Type 2 Diabetes
C-peptide is released from the pancreas in equal amounts to insulin but is not present in injected insulin, which makes it the reliable measure of your own beta cell function. Fasting normal is 0.5–2.0 ng/mL. A low C-peptide with high glucose indicates type 1 diabetes; a normal or high one indicates type 2.
Diabetes & Metabolic Diagnostics
1 Parameter
Serum (2 mL)
6 Hours
Preparation & Fasting Guidelines
Detailed Clinical Overview
Proinsulin, the precursor made in the beta cell, is cleaved into insulin and a connecting fragment called C-peptide, and both are secreted into the portal vein in exactly equal molar amounts. Insulin is then largely extracted by the liver on first pass, while C-peptide is not, and C-peptide's half-life of about 30 minutes is far longer than insulin's five. The result is that C-peptide gives a steadier, more representative picture of how much insulin the pancreas is actually making.
Its decisive advantage is that manufactured insulin preparations contain no C-peptide. In anyone taking insulin injections, measured serum insulin reflects the injection; C-peptide reflects only the person's own pancreas. This is what makes it the definitive test for residual beta cell function.
The clinical question it most often answers in India is whether a patient labelled type 2 is in fact type 1 or LADA — latent autoimmune diabetes in adults. Adults presenting with diabetes at a normal weight, with rapid progression to insulin, or with poor response to oral agents, may be autoimmune rather than insulin resistant, and the treatment differs entirely.
Why Get Tested at QXL Diagnostics?
Frequently Asked Questions
Q: What is the normal C-peptide level?
A: 0.5 to 2.0 ng/mL fasting, equivalent to 0.17 to 0.66 nmol/L. A stimulated value after a meal or glucagon is typically 1.0 to 4.0 ng/mL. The number is only interpretable alongside the blood glucose measured at the same moment.
Q: How does C-peptide distinguish type 1 from type 2 diabetes?
A: In type 1 diabetes the beta cells are destroyed, so C-peptide is very low or undetectable despite a high glucose. In type 2 diabetes the pancreas is still producing insulin, often more than normal, so C-peptide is normal or high. This distinction determines whether insulin is essential or optional.
Q: Why measure C-peptide instead of insulin?
A: Manufactured insulin contains no C-peptide, so in anyone taking insulin injections a measured insulin level reflects the injection rather than the pancreas. C-peptide comes only from your own beta cells. It also has a longer half-life and is not extracted by the liver, so it gives a steadier picture.
Q: What does a low C-peptide mean?
A: A low C-peptide with a high blood glucose means your pancreas is producing little or no insulin, which points to type 1 diabetes or advanced beta cell failure and means insulin treatment is necessary. A low C-peptide with a normal glucose in someone who is not diabetic is simply appropriate.
Q: What is LADA and how is C-peptide used to detect it?
A: LADA is latent autoimmune diabetes in adults — a slowly progressive autoimmune diabetes that is often misdiagnosed as type 2. It should be suspected in a lean adult who progresses quickly to needing insulin. A low or falling C-peptide together with positive GAD antibodies confirms it, and it changes management substantially.
Q: Do I need to fast for a C-peptide test?
A: For a fasting C-peptide, yes — 8 to 12 hours with only water. Some clinical questions call for a stimulated C-peptide measured after a meal or a glucagon injection instead, so follow the specific instruction on your requisition.
Q: Can I take my insulin before a C-peptide test?
A: Yes. Unlike an insulin test, C-peptide is unaffected by injected insulin, which is precisely why it is used in people on insulin therapy. Do mention your insulin regimen so the result is interpreted alongside the glucose correctly.
Q: Does kidney disease affect C-peptide?
A: Yes. C-peptide is cleared by the kidneys, so it accumulates when kidney function is reduced and can read falsely high. In someone with chronic kidney disease, a normal-looking C-peptide may overstate how much insulin the pancreas is actually making.
Q: Can C-peptide be used to diagnose insulinoma?
A: It is central to it. During a documented episode of hypoglycaemia, an inappropriately high insulin with a high C-peptide indicates the pancreas is over-secreting — insulinoma or a sulphonylurea. High insulin with a low C-peptide indicates injected insulin instead. A sulphonylurea screen completes the picture.
Q: Can C-peptide improve over time in type 2 diabetes?
A: Yes. At first diagnosis, very high glucose suppresses beta cell function temporarily — an effect called glucose toxicity — and C-peptide can look deceptively low. Once glucose is controlled, C-peptide often recovers substantially, which is why an early low value should be rechecked before concluding the pancreas has failed.
Includes free doorstep home sample collection
Book Home Collection →Or call: +91 9964 639 639NABL Quality Guarantees
NABL Accredited (MC-6849)
ISO 15189:2022 quality compliance
Same-Day Digital Reports
Delivered straight to WhatsApp & Email
Free Doorstep Collection
Sterile vacuum containers & cold-chain kits
Home Collection Locations
View all 40+ Bengaluru areas →C-Peptide Test: Normal Range and How It Separates Type 1 from Type 2 Diabetes